YOLFTbeta
30

Staidson Beijing Biopharma

300204 · SHE · Healthcare / Biotechnology

17.03CNY-0.68 (-3.84%)

Price History

Full chart

Market Stats

Previous Close17.71
Open17.71
Day Range17.00 – 17.87
52-Week Range18.98 – 42.65
Volume8.71M
Market Cap11.07B
P/E (TTM)0.00
Forward P/E37.17
EPS-0.19
Dividend Yield0.00%
Beta0.44
50-Day Avg21.94
200-Day Avg25.27

About

Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research, development, production, and marketing of therapeutic and biological drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; chemical drugs; and drugs for urinary, intestinal, infectious, autoimmune, nervous system, and other diseases. It also provides treatments for respiratory and critical care illnesses, and neurological disorders. Its product portfolio includes Mouse Nerve Growth factor for injection, Compound Polyethylene Glycol Electrolyte Powder (IV), Aspirin enteric-coated tablets, Compound polyethylene glycol (3350) electrolyte oral solution, Compound polyethylene glycol (3350) electrolyte vitamin C powder. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Wang Chao
  • Employees491
  • HeadquartersNo. 36, Jingha 2nd Road, Beijing, China, 100176, China
  • Websitehttps://www.staidson.com

Leadership

  • Mr. Wang ChaoGeneral Manager · b. 1982
  • Mr. Shicheng Li CPADeputy GM, Financial Director & Head of Accounting · b. 1982
  • Ms. Zhang LeiHuman Resources Director · b. 1986
  • Mr. Maorong YuSecretary of the Board & Deputy GM · b. 1981
  • Mr. Lei TienDirector of Production Center · b. 1988

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue24.09M50.90M88.47M128.21M205.82M556.15M892.69M1.09B1.25B1.40B1.39B806.08M661.49M425.21M584.29M548.99M364.18M324.82M220.23M
Growth (%)-+111.29%+73.80%+44.92%+60.53%+170.22%+60.51%+22.44%+14.17%+12.46%-1.10%-41.92%-17.94%-35.72%+37.41%-6.04%-33.66%-10.81%-32.20%
Cost of Revenue8.40M10.74M14.13M14.32M23.25M28.96M44.01M61.33M67.73M70.58M76.96M74.81M80.88M77.64M116.43M101.77M74.60M62.27M50.08M
Gross Profit15.70M40.16M74.90M113.89M182.57M527.19M848.68M1.03B1.18B1.33B1.31B731.27M580.61M347.57M467.86M447.22M289.57M262.55M170.15M
Gross Margin65.15%78.90%84.67%88.83%88.70%94.79%95.07%94.39%94.57%94.97%94.45%90.72%87.77%81.74%80.07%81.46%79.52%80.83%77.26%
Operating Expense11.61M21.29M35.96M49.82M78.86M359.29M724.19M828.08M942.19M1.04B1.01B581.56M560.27M502.84M681.07M690.19M655.73M296.16M248.56M
Operating Income4.09M18.87M38.94M64.07M103.71M167.90M124.49M203.59M237.98M295.22M302.78M149.72M20.34M-155.27M-213.21M-242.97M-366.16M-33.61M-78.41M
Operating Margin16.97%37.07%44.02%49.97%50.39%30.19%13.95%18.63%19.07%21.04%21.82%18.57%3.08%-36.52%-36.49%-44.26%-100.54%-10.35%-35.60%
EBITDA5.53M24.85M47.62M69.68M129.94M204.93M144.32M251.66M263.08M318.62M327.78M178.49M51.79M-124.10M-178.03M-211.12M-333.67M-11.30M-55.69M
EBITDA Margin22.97%48.82%53.83%54.35%63.14%36.85%16.17%23.02%21.08%22.70%23.62%22.14%7.83%-29.19%-30.47%-38.46%-91.62%-3.48%-25.29%
Net Income3.76M16.42M35.36M57.50M104.26M160.24M109.57M195.28M211.08M257.27M263.03M134.06M27.30M-133.02M-137.40M-197.01M-398.89M-144.84M-77.76M
Net Income Margin15.61%32.26%39.97%44.85%50.66%28.81%12.27%17.87%16.91%18.33%18.95%16.63%4.13%-31.28%-23.52%-35.89%-109.53%-44.59%-35.31%
R&D-4.00M5.18M8.18M13.51M28.92M48.55M44.69M56.10M75.33M92.13M121.42M160.74M243.68M362.51M362.81M412.26M107.11M84.94M
R&D as % of Total Revenue-7.86%5.85%6.38%6.56%5.20%5.44%4.09%4.50%5.37%6.64%15.06%24.30%57.31%62.04%66.09%113.20%32.97%38.57%
Interest Expense1.47M1.55M936.99K100.51K24.92K36.53K83.76K103.18K797.50K223.67K406.35K750.79K1.27M1.17M841.27K473.65K1.35M712.90K8.49M
Interest Expense % of Total Revenue6.10%3.05%1.06%0.08%0.01%0.01%0.01%0.01%0.06%0.02%0.03%0.09%0.19%0.28%0.14%0.09%0.37%0.22%3.85%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets82.22M92.07M148.75M264.88M1.15B1.43B1.57B1.81B2.07B2.35B2.63B2.77B1.86B1.86B1.83B1.67B1.33B1.15B1.27B
Total Liabilities48.35M29.25M29.03M98.66M47.32M192.15M255.47M297.54M387.06M432.32M419.14M314.30M227.18M268.70M276.25M315.45M311.55M232.85M459.48M
Total Equity33.87M62.82M119.72M166.23M1.10B1.24B1.31B1.51B1.67B1.90B2.21B2.46B1.64B1.59B1.55B1.35B1.02B929.23M820.78M
Cash13.20M15.44M54.62M97.56M868.78M804.62M816.27M899.58M1.03B349.70M401.19M365.20M352.61M140.57M85.01M264.99M85.18M53.91M123.64M
Total Debt25.00M-11.00M77.50M----56.73M60.02M3.57M3.51M3.64M55.80M7.63M28.96M40.95M30.09M-
Net Debt11.80M-15.44M-43.62M-20.06M-868.78M-804.62M-816.27M-899.58M-975.42M-289.68M-397.63M-361.69M-348.97M-89.37M-74.06M-259.12M-44.23M-23.83M-

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow5.41M16.23M42.37M63.91M87.01M90.19M111.36M206.85M231.01M212.55M273.64M165.08M44.34M-114.60M-162.07M-175.60M-227.47M-63.68M-125.68M
Investing Cash Flow-4.34M-8.31M-11.24M-94.36M-68.15M-121.00M-46.28M-99.62M-90.76M-876.06M-79.82M-41.23M332.47M-140.29M142.66M321.32M16.99M4.21M-
Financing Cash Flow10.24M-5.69M8.06M73.38M752.36M-33.35M-53.36M-24.01M-15.96M-33.42M-138.45M-163.15M-389.65M43.75M-35.91M32.62M30.64M27.50M-
Capital Expenditure342.40K16.81M13.19M82.25M84.35M58.88M23.02M14.47M23.95M26.45M46.55M95.46M59.91M48.86M56.24M56.51M32.15M23.53M76.63M
Free Cash Flow5.07M-578.37K29.17M-18.34M2.66M31.31M88.34M192.38M207.05M186.10M227.09M69.62M-15.57M-163.46M-218.31M-232.12M-260.47M-87.21M-202.31M
Dividends Paid1.49M1.55M936.99K2.12M1.73M33.35M53.36M24.01M72.69M67.46M85.72M119.29M314.23M854.77K320.13K-1.02M543.16K1.09M
FCF to OCF93.67%-3.56%68.86%-28.70%3.06%34.71%79.33%93.01%89.63%87.56%82.99%42.17%-35.10%142.64%134.70%132.18%114.51%136.94%160.97%
Dividend Paid to FCF29.48%-268.63%3.21%-11.56%65.09%106.53%60.40%12.48%35.10%36.25%37.75%171.34%-2018.70%-0.52%-0.15%--0.39%-0.62%-0.54%

Earnings

Report DateJun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Apr 23, 2015Aug 24, 2015Oct 19, 2015Feb 19, 2016Apr 25, 2016Aug 23, 2016Oct 27, 2016Mar 20, 2017Apr 19, 2017Aug 21, 2017Oct 26, 2017Feb 12, 2018Apr 25, 2018Aug 27, 2018Oct 29, 2018Mar 4, 2019Apr 27, 2019Aug 27, 2019Oct 30, 2019Mar 17, 2020Apr 28, 2020Aug 28, 2020Oct 30, 2020Apr 20, 2021Aug 27, 2021Oct 29, 2021Mar 22, 2022Apr 21, 2022Aug 23, 2022Oct 28, 2022Mar 21, 2023Apr 26, 2023Aug 29, 2023Oct 26, 2023Jan 11, 2024Apr 16, 2024Aug 27, 2024Oct 25, 2024Mar 25, 2025Apr 16, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026
EPS Estimate-----------------------------------------------------------
EPS Actual0.040.050.100.080.110.070.070.100.100.04-0.010.080.050.130.150.110.130.140.080.120.130.180.110.140.160.170.080.120.090.050.030.060.020.01-0.03-0.05-0.11-0.05-0.04-0.09-0.14-0.02-0.05-0.12-0.15-0.09-0.10-0.22-0.07-0.45-0.010.00-0.01-0.28-0.00-0.05-0.01-0.10-0.02
Surprise-----------------------------------------------------------
Timing---------------After-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-market-----------Pre-market------After-hoursAfter-hours---After-hours----

Key Statistics & Ratios

Market Cap11.07B
Enterprise Value11.33B
Trailing P/E0.00
Forward P/E37.17
PEG Ratio0.00
Price / Sales59.00
Price / Book14.00
EPS-0.19
Book Value1.69
Revenue (TTM)187.53M
Gross Profit (TTM)140.15M
EBITDA-61.99M
Profit Margin-47.94%
Operating Margin-58.94%
Return on Equity-10.62%
Return on Assets-4.24%
Shares Outstanding541.34M
Shares Float275.05M
Beta0.44
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20191×
0.67May 17, 2019
20181×
0.25Mar 20, 2018
20171×
0.18Apr 28, 2017
20161×
0.20May 5, 2016
20151×
0.15Apr 9, 2015
20141×
0.05Apr 28, 2014
20131×
0.11Jun 3, 2013
20121×
0.07Apr 27, 2012

Stock Splits

  • May 5, 201613.9959:10
  • Apr 9, 201514:10
  • Jun 3, 201318:10
  • Apr 27, 201220:10